References
1. Titulaer, M.J. et al. Overlapping demyelinating syndromes and
anti–N-methyl-D-aspartate receptor encephalitis. Annals of
neurology 75 , 411-428 (2014).
2. Comi, G., Radaelli, M. & Soelberg Sørensen, P. Evolving concepts in
the treatment of relapsing multiple sclerosis. Lancet (London,
England) 389 , 1347-1356 (2017).
3. Shi, H. et al. NLRP3 activation and mitosis are mutually
exclusive events coordinated by NEK7, a new inflammasome component.Nature immunology 17 , 250-258 (2016).
4. Chivero, E.T. et al. HIV-1 Tat Primes and Activates Microglial
NLRP3 Inflammasome-Mediated Neuroinflammation. The Journal of
neuroscience : the official journal of the Society for Neuroscience37 , 3599-3609 (2017).
5. Rathinam, V.A. & Fitzgerald, K.A. Inflammasome Complexes: Emerging
Mechanisms and Effector Functions. Cell 165 , 792-800
(2016).
6. Miao, E.A., Rajan, J.V. & Aderem, A. Caspase-1-induced pyroptotic
cell death. Immunological reviews 243 , 206-214 (2011).
7. Gris, D. et al. NLRP3 plays a critical role in the development
of experimental autoimmune encephalomyelitis by mediating Th1 and Th17
responses. Journal of immunology (Baltimore, Md. : 1950)185 , 974-981 (2010).
8. Inoue, M., Williams, K.L., Gunn, M.D. & Shinohara, M.L. NLRP3
inflammasome induces chemotactic immune cell migration to the CNS in
experimental autoimmune encephalomyelitis. Proceedings of the
National Academy of Sciences of the United States of America109 , 10480-10485 (2012).
9. Halle, A. et al. The NALP3 inflammasome is involved in the
innate immune response to amyloid-beta. Nature immunology9 , 857-865 (2008).
10. Seppi, D. et al. Cerebrospinal fluid IL-1β correlates with
cortical pathology load in multiple sclerosis at clinical onset.Journal of neuroimmunology 270 , 56-60 (2014).
11. Hauptmann, J. et al. Interleukin-1 promotes autoimmune
neuroinflammation by suppressing endothelial heme oxygenase-1 at the
blood-brain barrier. Acta neuropathologica 140 , 549-567
(2020).
12. Mellergård, J., Edström, M., Vrethem, M., Ernerudh, J. & Dahle, C.
Natalizumab treatment in multiple sclerosis: marked decline of
chemokines and cytokines in cerebrospinal fluid. Multiple
sclerosis (Houndmills, Basingstoke, England) 16 , 208-217
(2010).
13. Carpintero, R. & Burger, D. IFNβ and glatiramer acetate trigger
different signaling pathways to regulate the IL-1 system in multiple
sclerosis. Communicative & integrative biology 4 ,
112-114 (2011).
14. Garris, C.S. et al. Defective sphingosine 1-phosphate
receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune
neuroinflammation. Nature immunology 14 , 1166-1172
(2013).
15. Wang, X. et al. OTUB1 inhibits CNS autoimmunity by preventing
IFN-γ-induced hyperactivation of astrocytes. The EMBO journal38 (2019).
16. Damsky, W. et al. The emerging role of Janus kinase
inhibitors in the treatment of autoimmune and inflammatory diseases.The Journal of allergy and clinical immunology 147 ,
814-826 (2021).
17. Baker, K.F. & Isaacs, J.D. Novel therapies for immune-mediated
inflammatory diseases: What can we learn from their use in rheumatoid
arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis,
Crohn’s disease and ulcerative colitis? Annals of the rheumatic
diseases 77 , 175-187 (2018).
18. Oetjen, L.K. et al. Sensory Neurons Co-opt Classical Immune
Signaling Pathways to Mediate Chronic Itch. Cell 171 ,
217-228.e213 (2017).
19. Hussain, M. et al. Basophil-derived IL-4 promotes
epicutaneous antigen sensitization concomitant with the development of
food allergy. The Journal of allergy and clinical immunology141 , 223-234.e225 (2018).
20. Corren, J. & Ziegler, S.F. TSLP: from allergy to cancer.Nature immunology 20 , 1603-1609 (2019).
21. Liang, Y. et al. Thymic stromal lymphopoietin epigenetically
upregulates Fc receptor γ subunit-related receptors on
antigen-presenting cells and induces T(H)2/T(H)17 polarization through
dectin-2. The Journal of allergy and clinical immunology144 , 1025-1035.e1027 (2019).
22. Gregory, S.G. et al. Interleukin 7 receptor alpha chain
(IL7R) shows allelic and functional association with multiple sclerosis.Nature genetics 39 , 1083-1091 (2007).
23. Samoilova, E.B., Horton, J.L., Hilliard, B., Liu, T.S. & Chen, Y.
IL-6-deficient mice are resistant to experimental autoimmune
encephalomyelitis: roles of IL-6 in the activation and differentiation
of autoreactive T cells. Journal of immunology (Baltimore, Md. :
1950) 161 , 6480-6486 (1998).
24. Duong, T.T., St Louis, J., Gilbert, J.J., Finkelman, F.D. &
Strejan, G.H. Effect of anti-interferon-gamma and anti-interleukin-2
monoclonal antibody treatment on the development of actively and
passively induced experimental allergic encephalomyelitis in the SJL/J
mouse. Journal of neuroimmunology 36 , 105-115 (1992).
25. Baker, D. et al. Control of established experimental allergic
encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity
within the central nervous system using monoclonal antibodies and TNF
receptor-immunoglobulin fusion proteins. European journal of
immunology 24 , 2040-2048 (1994).
26. Hartgring, S.A. et al. Critical proinflammatory role of
thymic stromal lymphopoietin and its receptor in experimental autoimmune
arthritis. Arthritis and rheumatism 63 , 1878-1887
(2011).
27. Furuya, M.Y. et al. Tofacitinib inhibits
granulocyte-macrophage colony-stimulating factor-induced NLRP3
inflammasome activation in human neutrophils. Arthritis research
& therapy 20 , 196 (2018).
28. Graus, F. et al. A clinical approach to diagnosis of
autoimmune encephalitis. The Lancet. Neurology 15 ,
391-404 (2016).
29. Lévesque, S.A. et al. Myeloid cell transmigration across the
CNS vasculature triggers IL-1β-driven neuroinflammation during
autoimmune encephalomyelitis in mice. The Journal of experimental
medicine 213 , 929-949 (2016).
30. Coll, R.C. et al. A small-molecule inhibitor of the NLRP3
inflammasome for the treatment of inflammatory diseases. Nature
medicine 21 , 248-255 (2015).
31. Fleischman, A.G. et al. The CSF3R T618I mutation causes a
lethal neutrophilic neoplasia in mice that is responsive to therapeutic
JAK inhibition. Blood 122 , 3628-3631 (2013).
32. Lin, X.L. et al. Heme oxygenase-1 directly binds STAT3 to
control the generation of pathogenic Th17 cells during neutrophilic
airway inflammation. Allergy 72 , 1972-1987 (2017).
33. Paré, A. et al. IL-1β enables CNS access to CCR2(hi)
monocytes and the generation of pathogenic cells through GM-CSF released
by CNS endothelial cells. Proceedings of the National Academy of
Sciences of the United States of America 115 , E1194-e1203
(2018).
34. Damasceno, L.E.A. et al. PKM2 promotes Th17 cell
differentiation and autoimmune inflammation by fine-tuning STAT3
activation. The Journal of experimental medicine 217(2020).
35. Wu, B. et al. The TGF-β superfamily cytokine Activin-A is
induced during autoimmune neuroinflammation and drives pathogenic Th17
cell differentiation. Immunity 54 , 308-323.e306 (2021).
36. Ciccia, F. et al. Type 3 innate lymphoid cells producing
IL-17 and IL-22 are expanded in the gut, in the peripheral blood,
synovial fluid and bone marrow of patients with ankylosing spondylitis.Annals of the rheumatic diseases 74 , 1739-1747 (2015).
37. Hatfield, J.K. & Brown, M.A. Group 3 innate lymphoid cells
accumulate and exhibit disease-induced activation in the meninges in
EAE. Cellular immunology 297 , 69-79 (2015).
38. Lv, J. et al. Airway epithelial TSLP production of TLR2
drives type 2 immunity in allergic airway inflammation. European
journal of immunology 48 , 1838-1850 (2018).
39. Martínez-López, M. et al. Microbiota Sensing by Mincle-Syk
Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and
Promotes Intestinal Barrier Integrity. Immunity 50 ,
446-461.e449 (2019).
40. Haas, J., Korporal, M., Schwarz, A., Balint, B. & Wildemann, B. The
interleukin-7 receptor α chain contributes to altered homeostasis of
regulatory T cells in multiple sclerosis. European journal of
immunology 41 , 845-853 (2011).
41. Eckhardt, J. et al. Thymic stromal lymphopoietin deficiency
attenuates experimental autoimmune encephalomyelitis. Clinical and
experimental immunology 181 , 51-64 (2015).
42. Lee, H.C. et al. Hepatitis C virus promotes T-helper (Th)17
responses through thymic stromal lymphopoietin production by infected
hepatocytes. Hepatology (Baltimore, Md.) 57 , 1314-1324
(2013).
43. Hirota, K. et al. Autoimmune Th17 Cells Induced Synovial
Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to
Initiate and Augment Autoimmune Arthritis. Immunity 48 ,
1220-1232.e1225 (2018).
44. Suto, H. et al. IL-25 enhances T(H)17 cell-mediated contact
dermatitis by promoting IL-1β production by dermal dendritic cells.The Journal of allergy and clinical immunology 142 ,
1500-1509.e1510 (2018).
45. Wilson, S.R. et al. The epithelial cell-derived atopic
dermatitis cytokine TSLP activates neurons to induce itch. Cell155 , 285-295 (2013).
46. Mishra, S.K. et al. Periostin Activation of Integrin
Receptors on Sensory Neurons Induces Allergic Itch. Cell reports31 , 107472 (2020).
47. Kitic, M. et al. Thymic stromal lymphopoietin is expressed in
the intact central nervous system and upregulated in the
myelin-degenerative central nervous system. Glia 62 ,
1066-1074 (2014).
48. Hodecker, S.C. et al. Ruxolitinib treatment in a patient with
neuromyelitis optica: A case report. Neurology(R) neuroimmunology
& neuroinflammation 4 , e328 (2017).
49. Wallace, D.J. et al. Baricitinib for systemic lupus
erythematosus: a double-blind, randomised, placebo-controlled, phase 2
trial. Lancet (London, England) 392 , 222-231 (2018).
50. van der Heijde, D. et al. Tofacitinib in patients with
ankylosing spondylitis: a phase II, 16-week, randomised,
placebo-controlled, dose-ranging study. Annals of the rheumatic
diseases 76 , 1340-1347 (2017).
51. Schattling, B. et al. TRPM4 cation channel mediates axonal
and neuronal degeneration in experimental autoimmune encephalomyelitis
and multiple sclerosis. Nature medicine 18 , 1805-1811
(2012).
52. Fang, D. et al. Interleukin-6-mediated functional
upregulation of TRPV1 receptors in dorsal root ganglion neurons through
the activation of JAK/PI3K signaling pathway: roles in the development
of bone cancer pain in a rat model. Pain 156 , 1124-1144
(2015).
53. Malsch, P. et al. Deletion of interleukin-6 signal transducer
gp130 in small sensory neurons attenuates mechanonociception and
down-regulates TRPA1 expression. The Journal of neuroscience : the
official journal of the Society for Neuroscience 34 , 9845-9856
(2014).
54. Torke, S. et al. Inhibition of Bruton’s tyrosine kinase
interferes with pathogenic B-cell development in inflammatory CNS
demyelinating disease. Acta neuropathologica 140 ,
535-548 (2020).
55. Montalban, X. et al. Placebo-Controlled Trial of an Oral BTK
Inhibitor in Multiple Sclerosis. The New England journal of
medicine 380 , 2406-2417 (2019).